Preoperative assessment of high-risk candidates to predict survival after heart transplantation

Circulation: Heart Failure

Volumn 6, Issue 3, 2013, Pages 527-534

  Schulze, P Christian ^a   Jiang, Jeffrey ^a   Yang, Jonathan ^a   Cheema, Faisal H ^a   Schaeffle, Kenneth ^a   Kato, Tomoko S ^a   Farr, Maryjane ^a   Restaino, Susan ^a   Deng, Mario ^a   Maurer, Mathew ^a   Horn, Evelyn ^a   Latif, Farhana ^a   Colombo, Paolo C ^a   Jorde, Ulrich ^a   Uriel, Nir ^a   Haythe, Jennifer ^a   Bijou, Rachel ^a   Drusin, Ron ^a   Lee, Sun Hi ^a   Takayama, Hiroo ^a   Naka, Yoshifumi ^a   Mancini, Donna M ^a   more..

^a Department of Medicine   (United States)

Author keywords

Heart failure; Prognosis; Transplantation

Indexed keywords

ALBUMIN; AZATHIOPRINE; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIAC GRAFT REJECTION; CARRS SCORE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART AMYLOIDOSIS; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOPLASM; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RETRANSPLANTATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; STERNOTOMY; SURVIVAL PREDICTION; VENTRICULAR ASSIST DEVICE; WOUND INFECTION;

HEART FAILURE; PROGNOSIS; TRANSPLANTATION;

ADULT; AMYLOIDOSIS; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS;

EID: 84879214418     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000092     Document Type: Article

References (18)

1. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant. 2010;29:1089-1103.
2. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25:1024-1042.
3. Chen JM, Russo MJ, Hammond KM, Mancini DM, Kherani AR, Fal JM, Mazzeo PA, Pinney SP, Edwards NM, Naka Y. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg. 2005;80:224-228.
4. Forni A, Luciani GB, Chiominto B, Pizzuti M, Mazzucco A, Faggian G. Results with expanded donor acceptance criteria in heart transplantation. Transplant Proc. 2011;43:953-959.
5. Lietz K, John R, Mancini DM, Edwards NM. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria. J Am Coll Cardiol. 2004;43:1553-1561.
6. Russo MJ, Davies RR, Hong KN, Chen JM, Argenziano M, Moskowitz A, Ascheim DD, George I, Stewart AS, Williams M, Gelijns A, Naka Y. Matching high-risk recipients with marginal donor hearts is a clinically effective strategy. Ann Thorac Surg. 2009;87:1066-1070; discussion 1071.
7. Felker GM, Milano CA, Yager JE, Hernandez AF, Blue L, Higginbotham MB, Lodge AJ, Russell SD. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant. 2005;24:1781-1786.
8. Laks H, Scholl FG, Drinkwater DC, Blitz A, Hamilton M, Moriguchi J, Fonarow G, Kobashigawa J
9. Kobashigawa JA, Laks H, Wu G, Patel J, Moriguchi J, Hamilton M, Fonarow G, Fishbein M, Ardehali A. The University of California at Los Angeles heart transplantation experience. Clin Transpl. 2005:173-185.
10. Rajagopal K, Lima B, Petersen RP, Mesis RG, Daneshmand MA, Lemaire A, Felker GM, Hernandez AF, Rogers JG, Lodge AJ, Milano CA. Infectious complications in extended criteria heart transplantation. J Heart Lung Transplant. 2008;27:1217-1221.
11. Arnaoutakis GJ, George TJ, Allen JG, Russell SD, Shah AS, Conte JV, Weiss ES. Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant. J Thorac Cardiovasc Surg. 2012;143:157-167 e151.
12. Kilic A, Weiss ES, Arnaoutakis GJ, George TJ, Conte JV, Shah AS, Yuh DD. Identifying recipients at high risk for graft failure after heart retransplantation. Ann Thorac Surg. 2012;93:712-716.
13. Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114(suppl 1):I27-I32.
14. Hong KN, Iribarne A, Worku B, Takayama H, Gelijns AC, Naka Y, Jeevanandam V, Russo MJ. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011;92:520-527; discussion 527.
15. Weiss ES, Allen JG, Arnaoutakis GJ, George TJ, Russell SD, Shah AS, Conte JV. Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg. 2011;92:914-921; discussion 921.
16. Laks H, Marelli D, Fonarow GC, Hamilton MA, Ardehali A, Moriguchi JD, Bresson J, Gjertson D, Kobashigawa JA; UCLA Heart Tranplant Group. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg. 2003;125:49-59.
17. Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, Hernandez AF, Rogers JG, Milano CA. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg. 2010;89:1205-1209; discussion 1210.
18. Kato TS, Chokshi A, Singh P, Khawaja T, Cheema F, Akashi H, Shahzad K, Iwata S, Homma S, Takayama H, Naka Y, Jorde U, Farr M, Mancini DM, Schulze PC. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail. 2011;4:546-553.